Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment

Boixeda, R.; Campins, L.; Juanola, J.; Force, L.

doi:10.1016/j.rceng.2020.07.004

Revista Clínica Española (English Edition)

ISSN: 2254-8874

Revista Clínica Española published its first issue in 1940 and is the body of expression of the Spanish Society of Internal Medicine (SEMI).
The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Revista Clínica Española is subject to a thorough double blind review of the received articles written in Spanish or English. Ten issues are published each year, including mostly originals, reviews and consensus documents.

Indexed in:

Current Contents / Clinical Medicine , JCR / SCI-Expanded, Index Medicus / Medline y Excerpta Medica / EMBASE

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.3

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

0.7

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.162

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.211

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Vol. 220. Issue 8.

Pages 526-529 (November 2020)

Lee este artículo en Español

Export reference

Download PDF

More article options

Statistics

Vol. 220. Issue 8.

Pages 526-529 (November 2020)

Correspondence

DOI: 10.1016/j.rceng.2020.07.004

Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment

¿Es la enfermedad pulmonar obstructiva crónica un factor protector en la infección por SARS-CoV-2? La importancia del tratamiento broncodilatador

Visits

1074

Download PDF

R. Boixedaa,b,c,

Corresponding author

rboixeda@csdm.cat
rboixeda@ub.edu

Corresponding author.

, L. Campinsd, J. Juanolab,e,f, L. Forcea,f, on behalf of the COCOHMAT group 1

a Servicio de Medicina Interna, Hospital de Mataró, Consorci Sanitari del Maresme (CSDM), Mataró, Barcelona, Spain

b Grup d’Estudi al Maresme de la Pneumònia Adquirida en la Comunitat i la MPOC (GEMP@C), Mataró, Barcelona, Spain

c Universidad de Barcelona, CIBERES Barcelona, Barcelona, Spain

d Servicio de Farmacia, Hospital de Mataró, CSDM, Mataró, Barcelona, Spain

e Servicio de Neumología, Hospital de Mataró, CSDM, Mataró, Barcelona, Spain

f Escola de Ciències de la Salut, Tecnocampus, Universitat Pompeu Fabra, Barcelona, Spain

This item has received

1074 Visits

Article information

Full Text

Bibliography

Download PDF

Statistics

Tables (1)

Table 1. Treatment with inhaled corticosteroids and anticholinergics in patients with COPD in series of patients hospitalized due to SARS-CoV-2, severe exacerbation of COPD, and patients in the stable phase (primary care).

Article

These are the options to access the full texts of the publication Revista Clínica Española (English Edition)

Member of the society

Subscriber

Contact

Member

Si es usted socio de FESEMI siga los siguientes pasos:

Diríjase desde aquí a la web de la >>>FESEMI<<< e inicie sesión mediante el formulario que se encuentra en la barra superior, pulsando sobre el candado.